EU regulators are investigating Snapchat over fears it's not doing enough to protect children from online harm.
MedPage Today on MSN
Misinformation Abounds in Influencers' Promotion of Prescription Drugs
Systematic review turned up inaccurate or misleading advice, weak regulatory oversight ...
Nutshell reports that CRM customization is crucial for aligning tools with business processes, enhancing user experience, and ...
I get particularly annoyed when I see headlines and quotes from supposed responsible citizens in the aftermath of a national disaster. A few days ago, we woke up to the umpteenth building collapse in ...
While healthcare fiduciary suits have struggled to get past the motion-to-dismiss stage, a federal judge shrugged off arguments that had been successful in other suits as inadequate at this stage.
A once-daily pill could change how doctors treat teens with hypertrophic cardiomyopathy, a genetic heart condition that can ...
Study of 2,197 patients with resistant depression finds 95 percent improved once parasympathetic and sympathetic ...
Blake Lively spoke out after a judge dismissed 10 out of 13 claims—including sexual harassment allegations—in her lawsuit ...
Concerned neighbors worried adding hundreds of new residents would worsen congestion on Highway 12, particularly during an ...
LONDON — European Union regulators are investigating Snapchat over concerns the platform isn’t doing enough to protect kids and exposing them to risks such as increased vulnerability to child ...
A growing body of research suggests that the success of healthcare AI systems hinges not on technical performance alone but on a far more complex and contested factor: trust. A new interdisciplinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results